Table 1.
Sex (%) | |
Male | 87 (52/60) |
Female | 13 (8/60) |
Age (y) | |
Mean | 57 |
Median | 56 |
Range | 16–97 |
Location (%) | |
Left ear | 52 (31/60) |
Right ear | 48 (29/60) |
Previous skin cancer (%) | 27 (16/60) |
BCC | 13 (8/60)* |
SCC | 7 (4/60) |
Melanoma | 7 (4/60) |
Pathology (%) | |
Superficial spreading | 33 (20/60) |
Lentigo | 20 (12/60) |
Nodular | 18 (11/60) |
Demoplastic | 5 (3/60) |
Malig blue nevus | 2 (1/60) |
Spindle | 2 (1/60) |
Not defined | 23 (14/60) |
Clark level (%) | |
I | 3 (2/60) |
II | 13 (8/60) |
III | 15 (9/60) |
IV | 68 (41/60) |
Breslow level (mm) | |
Mean | 1.65 |
Median (range) | 1.22 (in situ–5) |
Overall follow-up (mo) | |
Mean | 40.4 |
Median (range) | 37.5 (1–129) |
Time to recurrence (mo) | |
Mean (range) | 29 |
Median | 16 |
Range | 5–92 |
Recurrence (%) | 33.3 (20/60) |
None | 66.6 (40/60) |
Local | 15 (9/60) |
Metastatic | 12 (7/60) |
Both | 7 (4/60) |
BCC = basal cell carcinoma; SCC = squamous cell carcinoma.
One patient had both melanoma and basal cell skin cancer before the diagnosis and treatment of the external ear melanoma.